Literature DB >> 8012387

X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.

P Saugier-Veber1, A Munnich, D Bonneau, J M Rozet, M Le Merrer, R Gil, O Boespflug-Tanguy.   

Abstract

Three forms of X-linked spastic paraplegia (SPG) have been defined. One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2). A rare X-linked dysmyelinating disorder of the central nervous system, Pelizaeus-Merzbacher disease (PMD), has also been mapped to Xq21-q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20. While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene. We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20, and segregates with the disease (Zmax = 6.63, theta = 0.00). It appears, therefore, that SPG2 and PMD are allelic disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012387     DOI: 10.1038/ng0394-257

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  71 in total

1.  A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34.

Authors:  B Fontaine; C S Davoine; A Dürr; C Paternotte; I Feki; J Weissenbach; J Hazan; A Brice
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 3.  Is the transportation highway the right road for hereditary spastic paraplegia?

Authors:  Andrew H Crosby; Christos Proukakis
Journal:  Am J Hum Genet       Date:  2002-09-24       Impact factor: 11.025

4.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

5.  A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR.

Authors:  K Inoue; H Osaka; N Sugiyama; C Kawanishi; H Onishi; A Nezu; K Kimura; Y Yamada; K Kosaka
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

6.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

7.  Hereditary spastic paraplegia: LOD-score considerations for confirmation of linkage in a heterogeneous trait.

Authors:  M P Dubé; M A Mlodzienski; Z Kibar; M R Farlow; G Ebers; P Harper; E H Kolodny; G A Rouleau; D A Figlewicz
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

8.  Decreased number and increased volume with mitochondrial enlargement of cerebellar synaptic terminals in a mouse model of chronic demyelination.

Authors:  Huy Bang Nguyen; Yang Sui; Truc Quynh Thai; Kazuhiro Ikenaka; Toshiyuki Oda; Nobuhiko Ohno
Journal:  Med Mol Morphol       Date:  2018-05-23       Impact factor: 2.309

9.  A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22.

Authors:  L Tranebjaerg; C Schwartz; H Eriksen; S Andreasson; V Ponjavic; A Dahl; R E Stevenson; M May; F Arena; D Barker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

10.  Towards fully automated genotyping: use of an X linked recessive spastic paraplegia family to test alternative analysis methods.

Authors:  H Kobayashi; T C Matise; M W Perlin; H G Marks; E P Hoffman
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.